Malignant Neoplasm of the Brain B030
Current RMA Instruments
| Reasonable Hypothesis SOP | 85 of 2016 |
| Balance of Probabilities SOP | 86 of 2016 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 191
- ICD-10-AM Codes: C71
Brief description
This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.
Confirming the diagnosis
Histological confirmation is required for diagnosis.
The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.
Diagnoses covered by SOP
Common
- astrocytoma of any grade or type
- glioblastoma (multiforme)
Uncommon
- astroblastoma
- choroid plexus carcinoma
- choriocarcinoma of the brain (primary)
- embryonal carcinoma of the brain (primary)
- ependymoblastoma
- ependymoma
- ganglioglyoma
- germinoma of the brain (primary)
- gliomatosis cerebri
- medulloblastoma
- medulloepithelioma
- neuroblastoma
- oligoastrocytoma
- oligodendroglioma
- pineoblastoma
- pineocytoma
- polar spongioblastoma
- teratoma of the brain (primary)
Conditions excluded from SOP
- acoustic neuroma*
- choroid plexus papilloma,# ICD code 225.0
- craniopharyngioma,# ICD code 237.0
- dysembryoplastic neuroepithelial tumour,# ICD code 225.0
- gangliocytoma,# (usually benign) ICD code 215.8
- haemangioblastoma,# - soft tissue sarcoma
- haemangiopericytoma,# - soft tissue sarcoma
- Hodgkin's lymphoma of the brain*
- meningioma*
- neurilemmoma* - acoustic neuroma
- neurofibroma,# ICD code 215.8
- non-Hodgkin's lymphoma of the brain*
- pituitary adenoma*
- schwannoma* - acoustic neuroma
- secondary/metastatic cancer involving the brain (code to primary cancer site)
- soft tissue sarcoma of the brain*
* another SOP applies
# non-SOP condition
Clinical onset
The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-brain-b030-c71
Rulebase for malignant neoplasm of the brain
<h5>Current RMA Instruments</h5><table border="1" cellpadding="1" cellspacing="1"><tbody><tr><td><a href="http://www.rma.gov.au/assets/SOP/2016/085.pdf" target="_blank"><em>Reasonable Hypothesis SOP</em></a></td><td>85 of 2016</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2016/086.pdf" target="_blank">Balance of Probabilities SOP</a></address></td><td>86 of 2016</td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="04c56b9c-a9c2-44f2-b9e8-dd4e0e1df37d" data-view-mode="wysiwyg"></drupal-media></p><h5>ICD Coding:</h5><ul><li>ICD-9-CM Codes: 191</li><li>ICD-10-AM Codes: C71</li></ul><h5><strong>Brief description</strong></h5><p>This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.</p><h5><strong>Confirming the diagnosis</strong></h5><p>Histological confirmation is required for diagnosis.</p><p>The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.</p><p><strong>Diagnoses covered by SOP </strong></p><p><u>Common</u></p><ul><li>astrocytoma of any grade or type</li><li>glioblastoma (multiforme)</li></ul><p><u>Uncommon</u></p><ul><li>astroblastoma</li><li>choroid plexus carcinoma</li><li>choriocarcinoma of the brain (primary)</li><li>embryonal carcinoma of the brain (primary)</li><li>ependymoblastoma</li><li>ependymoma</li><li>ganglioglyoma</li><li>germinoma of the brain (primary)</li><li>gliomatosis cerebri</li><li>medulloblastoma</li><li>medulloepithelioma</li><li>neuroblastoma</li><li>oligoastrocytoma</li><li>oligodendroglioma</li><li>pineoblastoma</li><li>pineocytoma</li><li>polar spongioblastoma</li><li>teratoma of the brain (primary)</li></ul><h5><strong>Conditions excluded from SOP</strong></h5><ul><li>acoustic neuroma*</li><li>choroid plexus papilloma,<sup><font size="2">#</font></sup> ICD code 225.0</li><li>craniopharyngioma,<sup><font size="2">#</font></sup> ICD code 237.0</li><li>dysembryoplastic neuroepithelial tumour,<sup><font size="2">#</font></sup> ICD code 225.0</li><li>gangliocytoma,<sup><font size="2">#</font></sup> (usually benign) ICD code 215.8</li><li>haemangioblastoma,<sup><font size="2">#</font></sup> - soft tissue sarcoma</li><li>haemangiopericytoma,<sup><font size="2">#</font></sup> - soft tissue sarcoma</li><li>Hodgkin's lymphoma of the brain*</li><li>meningioma*</li><li>neurilemmoma<sup><font size="2">* </font></sup>- acoustic neuroma</li><li>neurofibroma,<sup><font size="2">#</font></sup> ICD code 215.8</li><li>non-Hodgkin's lymphoma of the brain*</li><li>pituitary adenoma*</li><li>schwannoma<sup><font size="2">* </font></sup>- acoustic neuroma</li><li>secondary/metastatic cancer involving the brain (code to primary cancer site)</li><li>soft tissue sarcoma of the brain*</li></ul><p>* another SOP applies</p><p><sup><font size="2">#</font></sup> non-SOP condition</p><h5>Clinical onset</h5><p>The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.</p><h5>Clinical worsening</h5><p>The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.</p><p> </p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-brain-b030-c71/rulebase-malignant-neoplasm-brain
A course of therapeutic radiation to the head or neck
Current RMA Instruments
| Reasonable Hypothesis SOP | 85 of 2016 |
| Balance of Probabilities SOP | 86 of 2016 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 191
- ICD-10-AM Codes: C71
Brief description
This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.
Confirming the diagnosis
Histological confirmation is required for diagnosis.
The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.
Diagnoses covered by SOP
Common
- astrocytoma of any grade or type
- glioblastoma (multiforme)
Uncommon
- astroblastoma
- choroid plexus carcinoma
- choriocarcinoma of the brain (primary)
- embryonal carcinoma of the brain (primary)
- ependymoblastoma
- ependymoma
- ganglioglyoma
- germinoma of the brain (primary)
- gliomatosis cerebri
- medulloblastoma
- medulloepithelioma
- neuroblastoma
- oligoastrocytoma
- oligodendroglioma
- pineoblastoma
- pineocytoma
- polar spongioblastoma
- teratoma of the brain (primary)
Conditions excluded from SOP
- acoustic neuroma*
- choroid plexus papilloma,# ICD code 225.0
- craniopharyngioma,# ICD code 237.0
- dysembryoplastic neuroepithelial tumour,# ICD code 225.0
- gangliocytoma,# (usually benign) ICD code 215.8
- haemangioblastoma,# - soft tissue sarcoma
- haemangiopericytoma,# - soft tissue sarcoma
- Hodgkin's lymphoma of the brain*
- meningioma*
- neurilemmoma* - acoustic neuroma
- neurofibroma,# ICD code 215.8
- non-Hodgkin's lymphoma of the brain*
- pituitary adenoma*
- schwannoma* - acoustic neuroma
- secondary/metastatic cancer involving the brain (code to primary cancer site)
- soft tissue sarcoma of the brain*
* another SOP applies
# non-SOP condition
Clinical onset
The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-brain-b030-c71/rulebase-malignant-neoplasm-brain/course-therapeutic-radiation-head-or-neck
Atomic radiation
Current RMA Instruments
| Reasonable Hypothesis SOP | 85 of 2016 |
| Balance of Probabilities SOP | 86 of 2016 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 191
- ICD-10-AM Codes: C71
Brief description
This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.
Confirming the diagnosis
Histological confirmation is required for diagnosis.
The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.
Diagnoses covered by SOP
Common
- astrocytoma of any grade or type
- glioblastoma (multiforme)
Uncommon
- astroblastoma
- choroid plexus carcinoma
- choriocarcinoma of the brain (primary)
- embryonal carcinoma of the brain (primary)
- ependymoblastoma
- ependymoma
- ganglioglyoma
- germinoma of the brain (primary)
- gliomatosis cerebri
- medulloblastoma
- medulloepithelioma
- neuroblastoma
- oligoastrocytoma
- oligodendroglioma
- pineoblastoma
- pineocytoma
- polar spongioblastoma
- teratoma of the brain (primary)
Conditions excluded from SOP
- acoustic neuroma*
- choroid plexus papilloma,# ICD code 225.0
- craniopharyngioma,# ICD code 237.0
- dysembryoplastic neuroepithelial tumour,# ICD code 225.0
- gangliocytoma,# (usually benign) ICD code 215.8
- haemangioblastoma,# - soft tissue sarcoma
- haemangiopericytoma,# - soft tissue sarcoma
- Hodgkin's lymphoma of the brain*
- meningioma*
- neurilemmoma* - acoustic neuroma
- neurofibroma,# ICD code 215.8
- non-Hodgkin's lymphoma of the brain*
- pituitary adenoma*
- schwannoma* - acoustic neuroma
- secondary/metastatic cancer involving the brain (code to primary cancer site)
- soft tissue sarcoma of the brain*
* another SOP applies
# non-SOP condition
Clinical onset
The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-brain-b030-c71/rulebase-malignant-neoplasm-brain/atomic-radiation
Infection with the human immunodeficiency virus (HIV)
Current RMA Instruments
| Reasonable Hypothesis SOP | 85 of 2016 |
| Balance of Probabilities SOP | 86 of 2016 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 191
- ICD-10-AM Codes: C71
Brief description
This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.
Confirming the diagnosis
Histological confirmation is required for diagnosis.
The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.
Diagnoses covered by SOP
Common
- astrocytoma of any grade or type
- glioblastoma (multiforme)
Uncommon
- astroblastoma
- choroid plexus carcinoma
- choriocarcinoma of the brain (primary)
- embryonal carcinoma of the brain (primary)
- ependymoblastoma
- ependymoma
- ganglioglyoma
- germinoma of the brain (primary)
- gliomatosis cerebri
- medulloblastoma
- medulloepithelioma
- neuroblastoma
- oligoastrocytoma
- oligodendroglioma
- pineoblastoma
- pineocytoma
- polar spongioblastoma
- teratoma of the brain (primary)
Conditions excluded from SOP
- acoustic neuroma*
- choroid plexus papilloma,# ICD code 225.0
- craniopharyngioma,# ICD code 237.0
- dysembryoplastic neuroepithelial tumour,# ICD code 225.0
- gangliocytoma,# (usually benign) ICD code 215.8
- haemangioblastoma,# - soft tissue sarcoma
- haemangiopericytoma,# - soft tissue sarcoma
- Hodgkin's lymphoma of the brain*
- meningioma*
- neurilemmoma* - acoustic neuroma
- neurofibroma,# ICD code 215.8
- non-Hodgkin's lymphoma of the brain*
- pituitary adenoma*
- schwannoma* - acoustic neuroma
- secondary/metastatic cancer involving the brain (code to primary cancer site)
- soft tissue sarcoma of the brain*
* another SOP applies
# non-SOP condition
Clinical onset
The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-brain-b030-c71/rulebase-malignant-neoplasm-brain/infection-human-immunodeficiency-virus-hiv
No appropriate clinical management for malignant neoplasm of the brain
Current RMA Instruments
| Reasonable Hypothesis SOP | 85 of 2016 |
| Balance of Probabilities SOP | 86 of 2016 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 191
- ICD-10-AM Codes: C71
Brief description
This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.
Confirming the diagnosis
Histological confirmation is required for diagnosis.
The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.
Diagnoses covered by SOP
Common
- astrocytoma of any grade or type
- glioblastoma (multiforme)
Uncommon
- astroblastoma
- choroid plexus carcinoma
- choriocarcinoma of the brain (primary)
- embryonal carcinoma of the brain (primary)
- ependymoblastoma
- ependymoma
- ganglioglyoma
- germinoma of the brain (primary)
- gliomatosis cerebri
- medulloblastoma
- medulloepithelioma
- neuroblastoma
- oligoastrocytoma
- oligodendroglioma
- pineoblastoma
- pineocytoma
- polar spongioblastoma
- teratoma of the brain (primary)
Conditions excluded from SOP
- acoustic neuroma*
- choroid plexus papilloma,# ICD code 225.0
- craniopharyngioma,# ICD code 237.0
- dysembryoplastic neuroepithelial tumour,# ICD code 225.0
- gangliocytoma,# (usually benign) ICD code 215.8
- haemangioblastoma,# - soft tissue sarcoma
- haemangiopericytoma,# - soft tissue sarcoma
- Hodgkin's lymphoma of the brain*
- meningioma*
- neurilemmoma* - acoustic neuroma
- neurofibroma,# ICD code 215.8
- non-Hodgkin's lymphoma of the brain*
- pituitary adenoma*
- schwannoma* - acoustic neuroma
- secondary/metastatic cancer involving the brain (code to primary cancer site)
- soft tissue sarcoma of the brain*
* another SOP applies
# non-SOP condition
Clinical onset
The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-brain-b030-c71/rulebase-malignant-neoplasm-brain/no-appropriate-clinical-management-malignant-neoplasm-brain
Organ transplant
Current RMA Instruments
| Reasonable Hypothesis SOP | 85 of 2016 |
| Balance of Probabilities SOP | 86 of 2016 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 191
- ICD-10-AM Codes: C71
Brief description
This SOP covers cancers arising in the brain tissue itself, but not neoplasms of adjacent structures (e.g. meninges, pituitary gland), nor brain tumours of lymph or connective tissue (lymphomas and sarcomas), nor secondary brain tumours originating from other sites. There are more than 100 types of tumours that can affect the brain and the terminology can be confusing. The distinction between benign and malignant brain tumours is also less clear cut than for tumours arising at other sites.
Confirming the diagnosis
Histological confirmation is required for diagnosis.
The relevant medical specialist is a neurosurgeon, neurologist, or oncologist.
Diagnoses covered by SOP
Common
- astrocytoma of any grade or type
- glioblastoma (multiforme)
Uncommon
- astroblastoma
- choroid plexus carcinoma
- choriocarcinoma of the brain (primary)
- embryonal carcinoma of the brain (primary)
- ependymoblastoma
- ependymoma
- ganglioglyoma
- germinoma of the brain (primary)
- gliomatosis cerebri
- medulloblastoma
- medulloepithelioma
- neuroblastoma
- oligoastrocytoma
- oligodendroglioma
- pineoblastoma
- pineocytoma
- polar spongioblastoma
- teratoma of the brain (primary)
Conditions excluded from SOP
- acoustic neuroma*
- choroid plexus papilloma,# ICD code 225.0
- craniopharyngioma,# ICD code 237.0
- dysembryoplastic neuroepithelial tumour,# ICD code 225.0
- gangliocytoma,# (usually benign) ICD code 215.8
- haemangioblastoma,# - soft tissue sarcoma
- haemangiopericytoma,# - soft tissue sarcoma
- Hodgkin's lymphoma of the brain*
- meningioma*
- neurilemmoma* - acoustic neuroma
- neurofibroma,# ICD code 215.8
- non-Hodgkin's lymphoma of the brain*
- pituitary adenoma*
- schwannoma* - acoustic neuroma
- secondary/metastatic cancer involving the brain (code to primary cancer site)
- soft tissue sarcoma of the brain*
* another SOP applies
# non-SOP condition
Clinical onset
The clinical presentation is highly variable. Initial symptoms may include headaches, seizures, focal neurological symptoms or cognitive dysfunction. Once the diagnosis has been confirmed, clinical onset can be backdated to the time of onset of the first symptoms that are clinically consistent with the location, size or other features of the tumour.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Appropriate treatment varies with the type and stage of the tumour and other factors. The natural history for most brain cancers is for disease progression.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-brain-b030-c71/rulebase-malignant-neoplasm-brain/organ-transplant